Parkinsons Disease
Anxiety Increases Freezing of Gait Severity in Individuals With Parkinson Disease

Anxiety Increases Freezing of Gait Severity in Individuals With Parkinson Disease

The authors suggest that anxiety should be routinely evaluated in patients with Parkinson disease who experience freezing of gait.

FDA Approves New Nuplazid Formulation, Dosage Strength

FDA Approves New Nuplazid Formulation, Dosage Strength

Nuplazid, a non-dopaminergic, selective serotonin inverse agonist, targets 5-HT2A receptors that are thought to be involved in Parkinson disease psychosis.

Acadia Addresses Concerns Over Nuplazid Safety in Parkinson Disease Patients

Acadia Addresses Concerns Over Nuplazid Safety in Parkinson Disease Patients

Concerns over Nuplazid were initially voiced in a CNN article in early April which reported that the drug had been associated with over 700 deaths since its launch in March 2017.

NfL Biomarker Assists With Parkinsonian Disorder Differentiation

NfL Biomarker Assists With Parkinsonian Disorder Differentiation

More specific biomarkers will be needed to differentiate between atypical parkinsonian disorders.

Advancing Pain Management: Human Studies

Advancing Pain Management: Human Studies

Research on monogenic disorders has made vital contributions to all aspects of medical care, including our understanding of pain pathophysiology.

Inhaled Levodopa for 'Off' Periods in Parkinson Disease

Inhaled Levodopa for 'Off' Periods in Parkinson Disease

Levodopa pill can wear off, but a powdered version can help patients during off periods.

Statins May Be Protective Against Parkinson's in Diabetes

Statins May Be Protective Against Parkinson's in Diabetes

The study suggests that statins may serve a greater purpose beyond control of lipids and cardiovascular events.

Active Music Therapy May Be Beneficial in Parkinson's

Active Music Therapy May Be Beneficial in Parkinson's

Researchers saw a beneficial effect in tests examining frontal lobe function and improvement in memory.

Dopaminergic Control of Striatal Cholinergic Interneurons May Cause Antipsychotic-Associated Parkinsonism

Dopaminergic Control of Striatal Cholinergic Interneurons May Cause Antipsychotic-Associated Parkinsonism

Research examines the underlying mechanisms for the disabling adverse effects associated with antipsychotic medications.

Urinary Biomarker of Parkinson Disease Identified

Urinary Biomarker of Parkinson Disease Identified

To date, there are no validated biomarkers to independently assess Parkinson Disease diagnosis and prognosis, or to measure disease severity.

Sign Up for Free e-newsletters